Skip to main content

Advertisement

Table 1 Quarterly consumption of representative antibiotics and antibacterial compound classes

From: Intensive care antibiotic consumption and resistance patterns: a cross-correlation analysis

Time DDD/1000 patient-days
Penicillins Cephalosporins Carbapenems Fluoroquinolones Aminoglycosides Other Piperacillin + tazobactam Ampicillin + enzyme inhibitors Amoxicillin  + enzyme inhibitors Ceftriaxone Cefuroxime Imipenem + enzyme inhibitor Meropenem Ertapenem
Quarter I 2012 27.66 352.71 184.89 72.38 12.44 218.81 27.66 0.00 0.00 341.92 2.37 66.01 64.70 54.18
Quarter II 2012 36.99 265.39 183.44 81.03 29.42 242.46 10.69 18.33 7.96 222.05 35.42 58.73 74.24 50.47
Quarter III 2012 151.70 266.49 245.93 126.71 27.72 319.52 13.40 122.35 8.01 199.17 52.86 93.63 92.09 60.20
Quarter IV 2012 60.22 231.60 159.33 77.81 23.55 246.94 21.00 39.22 0.00 191.74 36.19 67.68 77.88 13.76
Quarter I 2013 118.27 184.84 222.13 73.13 8.29 273.84 53.35 50.48 7.53 99.17 73.45 64.67 113.67 43.79
Quarter II 2013 110.80 148.78 210.68 80.47 21.77 346.61 32.67 60.68 13.63 81.03 55.82 70.31 90.73 49.64
Quarter III 2013 138.16 232.97 270.24 77.04 25.98 339.51 71.43 57.50 8.76 137.83 63.18 55.34 172.22 42.67
Quarter IV 2013 139.90 241.57 286.46 88.46 40.49 468.93 102.33 36.05 0.00 127.11 17.71 97.50 165.75 23.21